In this episode of BDO’s Health & Life Sciences Rx Podcast, BDO’s Howard Levine sits down with leaders from the Allen Institute for Brain Science, Comet Therapeutics, and McDermott Will & Emery to discuss how life sciences leaders can evaluate whether to continue pursuing a drug development program or cancel it.

In this episode of BDO’s Health &amp; Life Sciences Rx Podcast, BDO’s Howard Levine sits down with leaders from the Allen Institute for Brain Science, Comet Therapeutics, and McDermott Will &amp; Emery to discuss how life sciences leaders can evaluate whether to continue pursuing a drug development program or cancel it.

Knowing When to Call It Quits in Drug Development and Healthcare Innovations

BDO’s Health & Life Sciences Rx Podcast, hosted by The BDO Center for Healthcare Excellence & Innovation and the Life Sciences practice, seeks to provide insights into the trends disrupting healthcare and how companies can adapt and evolve in an ever-changing business landscape.

Business

News

Health & Fitness

Business News

BDO’s Health &amp; Life Sciences Rx Podcast, hosted by The BDO Center for Healthcare Excellence &amp; Innovation and the Life Sciences practice, seeks to provide insights into the trends disrupting healthcare and how companies can adapt and evolve in an ever-changing business landscape.

Share Knowing When to Call It Quits in Drug Development and Healthcare Innovations

Sign up to save your podcasts

Knowing When to Call It Quits in Drug Development and Healthcare Innovations

Knowing When to Call It Quits in Drug Development and Healthcare Innovations